Askling, Johan

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives

Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology

Iron Metabolism and DisordersGenetic factors in colorectal cancer

Cited by 273

Increased Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in First-Degree Relatives of Patients With Primary Sclerosing Cholangitis

Bergquist, A., Montgomery, S. M., Bahmanyar, S., Olsson, R., Danielsson, Å., Lindgren, S., Prytz, H., Hultcrantz, R., Lööf, L., Sandberg–Gertzén, H., et al. (2008) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 188

FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease

Saevarsdottir, S., Olafsdottir, T. A., Ivarsdottir, E. V., Halldorsson, G. H., Gunnarsdottir, K., Sigurdsson, A., Johannesson, A., Sigurdsson, J. K., Juliusdottir, T., Lund, S. H., et al. (2020) · Nature

Genetic Associations and EpidemiologyThyroid Disorders and Treatments

Cited by 137

Hepatobiliary cancer risk in patients with inflammatory bowel disease: a scandinavian population-based cohort study

Erichsen, R., Olén, O., Sachs, M. C., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Ludvigsson, J. F., & Sørensen, H. T. (2021) · Cancer Epidemiology, Biomarkers & Prevention

Inflammatory Bowel DiseaseCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 31